16.08.2013 Views

Download - Bayer HealthCare

Download - Bayer HealthCare

Download - Bayer HealthCare

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

The goals of the Animal Health Division are to maintain the health of animals and<br />

cure veterinary diseases, with the focus primarily on treating infectious diseases<br />

and repelling parasites. in livestock – animals that play a role in food production – the<br />

safety of drug and care products is paramount for food safety. Companion animals receive<br />

special attention in clinical practice: in view of the emotional ties that people have<br />

to them but also their close relationship to the family, it is vital that they receive dependable,<br />

easy-to-use and safe medication in order to safeguard both their well-being and<br />

that of their owners.<br />

With more than 100 different animal health and care products worldwide for livestock and<br />

companion animals, the division is one of the most successful suppliers in the field of<br />

veterinary medicine. Animal Health is well positioned in the steadily growing market for<br />

antiparasitic products for companion animals. The Advantage family of flea control<br />

products for dogs and cats was again one of <strong>Bayer</strong> <strong>HealthCare</strong>’s best-selling products<br />

in 2012, generating annual sales of roughly € 495 million.<br />

The innovative flea and tick collar Seresto for dogs and cats joined the portfolio of<br />

parasiticides for companion animals in 2012. The collar’s patented polymer matrix<br />

ensures controlled low-dose release of the tried and true active ingredients flumethrin<br />

and imidacloprid into the animal’s coat. Seresto provides effective protection for up to<br />

eight months from a single application, and is available on the market in Europe, the<br />

United States and new Zealand.<br />

The acquisition of the animal health business of Teva Pharmaceuticals in the United<br />

States has strengthened both the companion animals and farm animals businesses<br />

and means that <strong>Bayer</strong> is now represented in all major therapeutic areas. The companion<br />

animal products acquired comprise mainly a complete range of dermatological<br />

products but also a wide spectrum of dietary supplements to support joint and<br />

gastrointestinal functions and other whole body health care products, while the farm<br />

animal products acquired from Teva cover a wide range of anti-infectives, parasiticides,<br />

anti-inflammatories and reproduction hormones.<br />

<strong>Bayer</strong> has signed a distribution agreement with the Irish veterinary manufacturer<br />

norbrook in Germany and France with the objective of supplementing the existing<br />

portfolio so that customers can be offered comprehensive solutions.<br />

AniMAl HEAlTH DIVISIOn<br />

7

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!